preclinics discovery is a subsidiary of preclinics GmbH.
We provide services in preclinical research for human medicine. Get an overview of our newest pharmaceutical product developments here.
Our extensive offer includes:
- BoNTANA Therapies: Advanced therapeutic concepts for unique, patient-centered neurotoxin treatments.
- ImmUnion: Develops active and passive vaccines that use the potential of a patient’s existing tetanus immunity to protect themselves against new pathogens.
- SerpinX: Our candidates to block inflammations and coagulation pathways.
- Xenodoma: The focus of Xenodoma is on the production of proteins, cells, tissues and organs in transgenic organisms.
For more information:
BoNTANA Therapies
ImmUnion
SerpinX
Xenodoma
The project is supported by the Ministry for Economic Affairs, Labour and Energy of the Federal State of Brandenburg (MWAE) from funds of the European Social Fund (ESF) and the Federal State of Brandenburg.
Links to funding agency:
European Commission www.ec.europa.eu
ESF-Website www.esf.brandenburg.de
Additional offer
Our parent company preclinics GmbH can gladly support you in all fee for services issues from the fields of immunisation, antibody production, protein expression and purification, preclinical studies and assay development.
For further information, please click here.
